Evidence map›Paper›PMID 22753936›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Transcription factor zinc finger and BTB domain 1 is essential for lymphocyte development.

Divya Punwani, Karen Simon, Youngnim Choi, Amalia Dutra, Diana Gonzalez-Espinosa, Evgenia Pak, Martin Naradikian, Chang-Hwa Song, Jenny Zhang, David M Bodine and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Zbtb1 controls NKp46Oncotarget · 2017
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Divya PunwaniDepartment of Pediatrics, University of California San Francisco, San Francisco, CA 91413, USA.
Karen Simon
Youngnim Choi
Amalia Dutra
Diana Gonzalez-Espinosa
Evgenia Pak
Martin Naradikian
Chang-Hwa Song
Jenny Zhang
David M Bodine
Jennifer M Puck
University of San Francisco · USNational Human Genome Research Institute · USChungnam National University · KRNational Institutes of Health · USSeoul National University · KRUniversity of California, San Francisco · US

Funding

NHGRI/DIR Cytogenetics and Microscopy CoreZICHG200348 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI WINCOVITCH, STEPHEN · 2010 to 2025
$20.3M
Hematopoietic Stem Cell BiologyZIAHG000083 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BODINE, DAVID M. · 2009 to 2022
$12.1M
Inherited Disorders of Lymphocyte DevelopmentR01AI078248 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI PUCK, JENNIFER M. · 2010 to 2014
$1.9M
Intramural NIH HHSNIAID NIH HHS R01 AI078248
6 · The paper itself

Abstract

Absent T lymphocytes were unexpectedly found in homozygotes of a transgenic mouse from an unrelated project. T cell development did not progress beyond double-negative stage 1 thymocytes, resulting in a hypocellular, vestigial thymus. B cells were present, but NK cell number and B cell isotype switching were reduced. Transplantation of wild-type hematopoietic cells corrected the defect, which was traced to a deletion involving five contiguous genes at the transgene insertion site on chromosome 12C3. Complementation using bacterial artificial chromosome transgenesis implicated zinc finger BTB-POZ domain protein 1 (Zbtb1) in the immunodeficiency, confirming its role in T cell development and suggesting involvement in B and NK cell differentiation. Targeted disruption of Zbtb1 recapitulated the T(-)B(+)NK(-) SCID phenotype of the original transgenic animal. Knockouts for Zbtb1 had expanded populations of bone marrow hematopoietic stem cells and also multipotent and early lymphoid lineages, suggesting a differentiation bottleneck for common lymphoid progenitors. Expression of mRNA encoding Zbtb1, a predicted transcription repressor, was greatest in hematopoietic stem cells, thymocytes, and pre-B cells, highlighting its essential role in lymphoid development.

Indexed as

AnimalsCell DifferentiationHematopoietic Stem CellsLymphocyte SubsetsMiceMice, Inbred C57BLMice, KnockoutMice, SCIDMice, TransgenicNIH 3T3 CellsPrecursor Cells, B-LymphoidPrecursor Cells, T-LymphoidRepressor ProteinsRNA, MessengerZinc FingersRepressor ProteinsRNA, MessengerZBTB1 protein, humanZBTB1 protein, mouse

Identifiers

PMID22753936
PMCPMC3401355
OpenAlexW2148622691

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.